242 related articles for article (PubMed ID: 35632798)
1. Expanded Basal Compartment and Disrupted Barrier in Vocal Fold Epithelium Infected with Mouse Papillomavirus MmuPV1.
King RE; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632798
[TBL] [Abstract][Full Text] [Related]
2. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
3. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
4. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
5. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan in vocal folds and false vocal folds in patients with recurrent respiratory papillomatosis.
Holm A; Hellman U; Laurent C; Laurell G; Nylander K; Olofsson K
Acta Otolaryngol; 2018 Nov; 138(11):1020-1027. PubMed ID: 30776265
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Models of Laryngeal Papillomavirus Infection: A Scoping Review.
King RE; Bilger A; Rademacher J; Lambert PF; Thibeault SL
Laryngoscope; 2023 Dec; 133(12):3256-3268. PubMed ID: 37227124
[TBL] [Abstract][Full Text] [Related]
8. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
Antiviral Res; 2023 Aug; 216():105667. PubMed ID: 37429527
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
10. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
11. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.
Xue XY; Majerciak V; Uberoi A; Kim BH; Gotte D; Chen X; Cam M; Lambert PF; Zheng ZM
PLoS Pathog; 2017 Nov; 13(11):e1006715. PubMed ID: 29176795
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
13. A novel lineage-tracing mouse model for studying early MmuPV1 infections.
Yilmaz V; Louca P; Potamiti L; Panayiotidis M; Strati K
Elife; 2022 May; 11():. PubMed ID: 35533001
[TBL] [Abstract][Full Text] [Related]
14. Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W; Spurgeon ME; Pope A; McGregor S; Ward-Shaw E; Gronski E; Lambert PF
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2214225120. PubMed ID: 36917668
[TBL] [Abstract][Full Text] [Related]
15. Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case-control study).
Formánek M; Jančatová D; Komínek P; Matoušek P; Zeleník K
Clin Otolaryngol; 2017 Jun; 42(3):597-601. PubMed ID: 27759910
[TBL] [Abstract][Full Text] [Related]
16. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
17. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
18. Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort.
Benedict PA; Ruiz R; Yoo M; Verma A; Ahmed OH; Wang B; Dion GR; Voigt A; Merati A; Rosen CA; Amin MR; Branski RC
Laryngoscope; 2018 Jan; 128(1):138-143. PubMed ID: 28714564
[TBL] [Abstract][Full Text] [Related]
19. Sexual transmission of murine papillomavirus (MmuPV1) in
Spurgeon ME; Lambert PF
Elife; 2019 Oct; 8():. PubMed ID: 31621578
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis.
Kono T; Yabe H; Uno K; Saito K; Ogawa K
Laryngoscope; 2017 Mar; 127(3):679-684. PubMed ID: 27515839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
